Japan Invests ¥150 Million To Develop New Flu Virus Rapid Testing Kit
This article was originally published in PharmAsia News
Executive Summary
Japan National Institute of Infectious Disease, International Medical Center at Riken and Tokyo University established a partnership to research and develop a rapid diagnostic kit for the new H1N1 flu virus. The Japanese government has allocated ¥150 million from its science and technology renovation fund for the project. The kit will be able to test for the flu virus in as little as 30 minutes at every hospital, compared to current viral DNA testing that takes hours. The team aims to develop the technology by this winter. (Click here for more - Japanese language
You may also be interested in...
California Bill To Age-Restrict Sales Of Diet Pills Further Along Than Other States’ Legislation
CA, MA and NJ legislatures remain in session with bills active proposing regulations similar to NY law effective 22 April requiring retailers, including online, to ask for proof of age when customers buying consumer health products containing ingredients labeled or promoted for weight loss and bodybuilding benefits appear younger than 18.
CRN Has Standing For Steep Hill To Climb Challenging New York's Age-Restricted Sales
Federal judge finds “misreading of the legislation” in CRN’s argument that state “restricts access based purely on what has been said about the product or its ingredients.” But standing to challenge “means that only CRN is positioned right now to go before the court on behalf of industry,” says CEO Steve Mister.
Addition to Quest Alzheimer's Suite Looks For Biomarker P-Tau217
The test is being integrated into Quest’s AD-Detect portfolio for assessing the risk of Alzheimer’s. It is the third p-tau217 test to make news this month, after new breakthrough designations for Quanterix and Roche and Eli Lilly.